Micro-surgical Treatment of Gummy Smile

July 3, 2023 updated by: Marie-line Sherif Sourour, Cairo University

Evaluation of Pain Following Microsurgical Esthetic Crown Lengthening Using Flap Vs. Flapless Piezo-surgical Approach: A Randomized Controlled Clinical Trial

Compare pain response following microsurgical conventional flap approach using Piezosurgery versus flapless approach for esthetic crown lengthening in management of patients with short clinical crowns in the upper anterior region.

Study Overview

Detailed Description

The conventional approach: Anesthesia will be given followed by bone sounding using William graduated periodontal probe and measuring the pocket depth (using magnification loupes and microsurgical blades)

  • Marking the bleeding points
  • An internal bevel incision is made followed afterwards by a sulcular incision.
  • The gingival collar is eliminated.
  • Elevation of the flap is proceeded to allow access for osteoplasty using piezo surgery and an apical position of the bone 2-3mm beyond CEJ.
  • Mattress suture (6.0) is made

The intervention approach:

Surgery is done the same as in the conventional approach but without opening a flap, gaining access via a tunneling instrument and piezo tips for osteoplasty

Study Type

Interventional

Enrollment (Actual)

24

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt
        • Faculty of Oral and Dental Medecine-CU

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Patients with healthy systemic condition.
  2. Adult patients ˃ 18 years old.
  3. The presence of the six upper anterior teeth.
  4. Patients who have short clinical crowns due to altered passive eruption classified as Type I subclass B (Coslet, Vanarsdall and Weisgold, 1977).
  5. Absence of sites with attachment loss and probing depth (PD) >3 mm.
  6. Keratinized gingiva of at least 2mm width (Pontoriero and Carnevale, 2001).
  7. Compliance with good oral hygiene.
  8. Patients accepts 6-months follow-up period (cooperative patients).
  9. Patients provides an informed consent.

Exclusion Criteria:

  1. Presence of prosthetic crowns
  2. Extensive restorations
  3. Extensive incisal edge attrition.
  4. Smokers ˃ 10 cigarettes / day
  5. Pregnant females

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: The conventional approach
Conventionnal ECL using piezosurgery and microsurgical tools
excess gingiva is eliminated. 2 mm bone is removed from CEJ-bone crest with piezo surgery with conventional flap elevation.
Active Comparator: The intervention approach:
Conventionnal ECL with tunneling using piezosurgery and microsurgical tools
excess gingiva is eliminated. 2 mm bone is removed from CEJ-bone crest with piezo surgery via tunneling

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain VAS
Time Frame: 48 hours
Visual Analogue Scale for Pain (numbers from 0 to 10 ('no pain' to 'worst pain imaginable') measured daily for the first 2 days postoperative
48 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mid-buccal gingival margin level
Time Frame: 6 months
Periodontal probe with William's graduation will be used to measure the distance from a prefabricated grooved stent vertically- to the level of the gingival margin at the mid-buccal surface (measured at baseline, 3 and 6 months postoperatively)
6 months
Post-Surgical Patient Satisfaction.
Time Frame: 6 months
Numerical Rating Scale (A 3-item questionnaire is asked, and the patients shall use a 7-point answer scale. )
6 months
Pink Esthetic Score
Time Frame: 6 months

The PES is based on seven variables:

mesial papilla, distal papilla, soft-tissue level, soft tissue contour, alveolar process deficiency, soft-tissue color and texture. Each variable shall be assessed with a 2-1-0 score, with 2 being the best and 0 being the poorest score. The mesial and distal papilla will be evaluated for completeness, incompleteness or absence. All other variables will be assessed by comparison to a reference tooth.

6 months
Post-Surgical swelling
Time Frame: 14 days
Absent: no swelling, Slight: intraoral swelling at the operated area, Moderate: moderate intraoral swelling at the operated area and Intense: intensive extra oral swelling extending beyond the operated area. (Assessed in day 7 and 14 postoperatively)
14 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 6, 2020

Primary Completion (Actual)

December 6, 2021

Study Completion (Actual)

June 6, 2022

Study Registration Dates

First Submitted

May 21, 2020

First Submitted That Met QC Criteria

May 22, 2020

First Posted (Actual)

May 26, 2020

Study Record Updates

Last Update Posted (Actual)

July 5, 2023

Last Update Submitted That Met QC Criteria

July 3, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • PER3-3-1

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain, Postoperative

Clinical Trials on Micro-surgical crown lengthening approach using Piezosurgery

Subscribe